悦康药业向香港联交所递交H股发行上市申请并刊发申请资料

Core Viewpoint - The company,悦康药业, has submitted an application for the issuance of overseas listed foreign shares (H shares) and for listing on the main board of the Hong Kong Stock Exchange on December 29, 2025 [1] Group 1 - The application materials were prepared and published in accordance with the requirements of the Hong Kong Securities and Futures Commission and the Hong Kong Stock Exchange [1] - The submitted documents are in draft form and may be updated and revised as necessary [1] - Investors are advised not to make any investment decisions based solely on the information contained in the application materials [1]